Skip to Content

Neonatal Malignant Disorders, An Issue of Clinics in Perinatology, 1st Edition

Author :
Edited by Daniel S. Wechsler
In collaboration with Consulting Editor, Dr. Lucky Jain, Guest Editor Dr. Daniel Wechsler has assembled expert authors to provide a current update on the diagnosis and treatment of neonatal malignant disorders. Articles are specifically devoted to th ...view more
In collaboration with Consulting Editor, Dr. Lucky Jain, Guest Editor Dr. Daniel Wechsler has assembled expert authors to provide a current update on the diagnosis and treatment of neonatal malignant disorders. Articles are specifically devoted to the following topics:  Genetic Predisposition and Neonatal Cancer; Infant Leukemias; Neonatal Malignant Disorders: Brain Tumors; Retinoblastoma; Neonatal Malignant Disorders: Kidney Tumors; Neonatal Malignant Disorders: Liver Tumors; Neuroblastoma; Neonatal Malignant Disorders: Sarcoma; Neonatal Malignant Disorders: Germ Cell Tumors; Neonatal Histiocytoses; Lymphatic Malformations; and Long-Term Outcomes in Neonatal Cancer Survivors. Readers will come away with the information they need to improve outcomes in infants with neonatal malignant disorders.
ISBN :
9780323761666
Publication Date :
12-03-2021
Stock Status :
Please allow 10-14 working days for delivery
Earn 15 Points
Earn 10 Points
Add to Cart
In collaboration with Consulting Editor, Dr. Lucky Jain, Guest Editor Dr. Daniel Wechsler has assembled expert authors to provide a current update on the diagnosis and treatment of neonatal malignant disorders. Articles are specifically devoted to the following topics:  Genetic Predisposition and Neonatal Cancer; Infant Leukemias; Neonatal Malignant Disorders: Brain Tumors; Retinoblastoma; Neonatal Malignant Disorders: Kidney Tumors; Neonatal Malignant Disorders: Liver Tumors; Neuroblastoma; Neonatal Malignant Disorders: Sarcoma; Neonatal Malignant Disorders: Germ Cell Tumors; Neonatal Histiocytoses; Lymphatic Malformations; and Long-Term Outcomes in Neonatal Cancer Survivors. Readers will come away with the information they need to improve outcomes in infants with neonatal malignant disorders.

Author Information
Edited by Daniel S. Wechsler